Skip to main content

Table 2 Association of survivin and VEGF-C protein expression with clinicopathological features in breast cancer patients

From: Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer

Variable

n

Survivin-

Survivin+

χ2

p

VEGF-C -

VEGF-C +

χ2

p

Age

   

0

1

  

0.965

0.326

≤45 years

36

6

30

  

6

30

  

>45 years

72

12

60

  

18

54

  

Tumor size

   

9.305

0.01

  

4.102

0.129

T1

39

12

27

  

12

27

  

T2

60

6

54

  

9

51

  

T3

9

0

9

  

3

6

  

Histological grade

   

0.873

0.350

  

0.175

0.675

I + II

99

15

84

  

21

78

  

III

9

3

6

  

3

6

  

Pathological style

   

0.169

0.681

  

0

1

ISC

12

3

9

  

3

9

  

IC

96

15

81

  

21

75

  

Lymph node metastasis

   

16.283

0.000

  

18.544

0.000

Negative

30

12

18

  

15

15

  

Positive

78

6

72

  

9

69

  

C-erBb-2

   

8.269

0.004

  

4.354

0.037

positive(3 + )

12

6

6

  

6

6

  

negative(0-2 + )

96

12

84

  

18

78

  

ER

   

0.617

0.432

  

0.882

0.348

positive

63

9

54

  

12

51

  

negative

45

9

36

  

12

33

  

PR

   

0

1

  

1.929

0.165

positive

54

9

45

  

15

39

  

negative

54

9

45

  

9

45

  

TNM stage

   

10.800

0.001

  

6.027

0.014

I, II

72

18

54

  

21

51

  

III, IV

36

0

36

  

3

33

  
  1. ISC, in situ carcinoma; IC, invasive carcinoma.